Aehr Cost of Revenue vs Free Cash Flow Analysis
AEHR Stock | USD 11.15 0.44 3.80% |
Aehr Test financial indicator trend analysis is way more than just evaluating Aehr Test Systems prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aehr Test Systems is a good investment. Please check the relationship between Aehr Test Cost Of Revenue and its Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Cost Of Revenue vs Free Cash Flow
Cost of Revenue vs Free Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aehr Test Systems Cost of Revenue account and Free Cash Flow. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Aehr Test's Cost of Revenue and Free Cash Flow is 0.91. Overlapping area represents the amount of variation of Cost of Revenue that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Aehr Test Systems, assuming nothing else is changed. The correlation between historical values of Aehr Test's Cost of Revenue and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost of Revenue of Aehr Test Systems are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Cost of Revenue i.e., Aehr Test's Cost of Revenue and Free Cash Flow go up and down completely randomly.
Correlation Coefficient | 0.91 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Cost Of Revenue
Cost of Revenue is found on Aehr Test Systems income statement and represents the costs associated with goods and services Aehr Test provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Most indicators from Aehr Test's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aehr Test Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. At this time, Aehr Test's Tax Provision is relatively stable compared to the past year. As of 04/17/2024, Enterprise Value Over EBITDA is likely to grow to 63.14, while Selling General Administrative is likely to drop slightly above 8.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 23.7M | 32.7M | 37.7M | 39.5M | Total Revenue | 50.8M | 65.0M | 74.7M | 78.4M |
Aehr Test fundamental ratios Correlations
Click cells to compare fundamentals
Aehr Test Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aehr Test fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 20.6M | 21.7M | 62.3M | 98.1M | 112.9M | 118.5M | |
Other Current Liab | 1.4M | 2.2M | 3.6M | 4.1M | 3.7M | 1.9M | |
Total Current Liabilities | 3.9M | 9.1M | 11.0M | 16.3M | 18.8M | 19.7M | |
Total Stockholder Equity | 14.1M | 11.4M | 51.0M | 75.6M | 68.0M | 71.4M | |
Property Plant And Equipment Net | 2.8M | 2.3M | 2.1M | 8.9M | 10.2M | 10.7M | |
Net Debt | (1.5M) | 241K | (30.5M) | (23.8M) | (21.4M) | (20.3M) | |
Retained Earnings | (74.3M) | (76.3M) | (66.9M) | (52.3M) | (47.1M) | (49.4M) | |
Accounts Payable | 945K | 2.9M | 4.2M | 9.2M | 10.6M | 11.1M | |
Cash | 5.4M | 4.6M | 31.5M | 30.1M | 34.6M | 36.3M | |
Non Current Assets Total | 2.9M | 2.5M | 2.3M | 9.1M | 8.2M | 8.6M | |
Non Currrent Assets Other | 73K | 118K | 121K | 81K | 72.9K | 69.3K | |
Cash And Short Term Investments | 5.4M | 4.6M | 31.5M | 47.9M | 55.1M | 57.8M | |
Net Receivables | 3.7M | 5.2M | 12.9M | 16.6M | 19.1M | 20.0M | |
Common Stock Shares Outstanding | 22.9M | 23.5M | 27.8M | 29.2M | 33.6M | 35.3M | |
Liabilities And Stockholders Equity | 20.6M | 21.7M | 62.3M | 98.1M | 112.9M | 118.5M | |
Non Current Liabilities Total | 2.7M | 1.2M | 325K | 6.2M | 7.2M | 7.5M | |
Inventory | 8.0M | 8.8M | 15.1M | 23.9M | 27.5M | 28.9M | |
Other Current Assets | 512K | 551K | 613K | 621K | 558.9K | 861.9K | |
Other Stockholder Equity | 85.9M | 87.6M | 117.7M | 127.8M | 146.9M | 154.3M | |
Total Liab | 6.5M | 10.2M | 11.3M | 22.5M | 25.9M | 27.2M | |
Property Plant And Equipment Gross | 2.8M | 2.3M | 2.1M | 8.9M | 10.2M | 10.7M | |
Total Current Assets | 17.7M | 19.2M | 60.0M | 89.0M | 102.4M | 107.5M | |
Accumulated Other Comprehensive Income | 2.2M | (28K) | (105K) | (155K) | (178.3K) | (169.3K) | |
Current Deferred Revenue | 170K | 189K | 2.4M | 2.8M | 3.2M | 3.4M | |
Common Stock Total Equity | 221K | 227K | 231K | 237K | 272.6K | 286.2K | |
Common Stock | 231K | 237K | 271K | 285K | 327.8K | 344.1K | |
Other Liab | 22K | 148K | 113K | 72K | 64.8K | 61.6K | |
Other Assets | 153K | 198K | 201K | 231K | 207.9K | 380.5K | |
Property Plant Equipment | 2.8M | 2.3M | 2.1M | 8.9M | 10.2M | 10.7M | |
Net Tangible Assets | 14.1M | 11.4M | 51.0M | 75.6M | 86.9M | 91.3M | |
Retained Earnings Total Equity | (66.2M) | (71.5M) | (74.3M) | (76.3M) | (68.7M) | (72.1M) | |
Capital Surpluse | 85.9M | 87.6M | 117.7M | 127.8M | 146.9M | 85.6M | |
Deferred Long Term Liab | 522K | 342K | 22K | 99K | 113.9K | 173.1K |
Pair Trading with Aehr Test
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aehr Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aehr Test will appreciate offsetting losses from the drop in the long position's value.Moving together with Aehr Stock
0.72 | MX | MagnaChip Semiconductor Financial Report 1st of May 2024 | PairCorr |
Moving against Aehr Stock
0.9 | MU | Micron Technology Financial Report 26th of June 2024 | PairCorr |
0.82 | DM | Desktop Metal Financial Report 8th of May 2024 | PairCorr |
0.77 | ML | MoneyLion Financial Report 14th of May 2024 | PairCorr |
0.72 | PI | Impinj Inc Earnings Call This Week | PairCorr |
0.72 | GB | Global Blue Group | PairCorr |
The ability to find closely correlated positions to Aehr Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aehr Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aehr Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aehr Test Systems to buy it.
The correlation of Aehr Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aehr Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aehr Test Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aehr Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Aehr Test Systems information on this page should be used as a complementary analysis to other Aehr Test's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Aehr Stock analysis
When running Aehr Test's price analysis, check to measure Aehr Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aehr Test is operating at the current time. Most of Aehr Test's value examination focuses on studying past and present price action to predict the probability of Aehr Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aehr Test's price. Additionally, you may evaluate how the addition of Aehr Test to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Aehr Test's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aehr Test. If investors know Aehr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aehr Test listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.538 | Earnings Share 0.52 | Revenue Per Share 2.506 | Quarterly Revenue Growth (0.56) | Return On Assets 0.0885 |
The market value of Aehr Test Systems is measured differently than its book value, which is the value of Aehr that is recorded on the company's balance sheet. Investors also form their own opinion of Aehr Test's value that differs from its market value or its book value, called intrinsic value, which is Aehr Test's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aehr Test's market value can be influenced by many factors that don't directly affect Aehr Test's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aehr Test's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aehr Test is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aehr Test's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.